Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-005171
Filing Date
2019-05-17
Accepted
2019-05-17 12:28:41
Documents
106
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eglt-20190331x10q.htm 10-Q 2927402
2 EX-10.10 eglt-20190331ex101036682.htm EX-10.10 384301
3 EX-10.11 eglt-20190331ex10119c71d.htm EX-10.11 541890
4 EX-10.12 eglt-20190331ex1012aaa70.htm EX-10.12 339715
5 EX-10.18 eglt-20190331ex1018e8a80.htm EX-10.18 64302
6 EX-10.9 eglt-20190331ex109a8f997.htm EX-10.9 151156
7 EX-31.1 eglt-20190331ex311b92028.htm EX-31.1 17371
8 EX-32.1 eglt-20190331ex321f0e95c.htm EX-32.1 8925
  Complete submission text file 0001558370-19-005171.txt   14199770

Data Files

Seq Description Document Type Size
9 EX-101.INS eglt-20190331.xml EX-101.INS 3114248
10 EX-101.SCH eglt-20190331.xsd EX-101.SCH 88981
11 EX-101.CAL eglt-20190331_cal.xml EX-101.CAL 95258
12 EX-101.DEF eglt-20190331_def.xml EX-101.DEF 403314
13 EX-101.LAB eglt-20190331_lab.xml EX-101.LAB 642364
14 EX-101.PRE eglt-20190331_pre.xml EX-101.PRE 589091
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Egalet Corp (Filer) CIK: 0001586105 (see all company filings)

EIN.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36295 | Film No.: 19834867
SIC: 2834 Pharmaceutical Preparations